AU2001253495A1 - Treating graft rejection with ccr5 inhibitors - Google Patents
Treating graft rejection with ccr5 inhibitorsInfo
- Publication number
- AU2001253495A1 AU2001253495A1 AU2001253495A AU5349501A AU2001253495A1 AU 2001253495 A1 AU2001253495 A1 AU 2001253495A1 AU 2001253495 A AU2001253495 A AU 2001253495A AU 5349501 A AU5349501 A AU 5349501A AU 2001253495 A1 AU2001253495 A1 AU 2001253495A1
- Authority
- AU
- Australia
- Prior art keywords
- graft rejection
- ccr5 inhibitors
- treating graft
- treating
- ccr5
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54962500A | 2000-04-14 | 2000-04-14 | |
US09549625 | 2000-04-14 | ||
PCT/US2001/012206 WO2001078707A1 (en) | 2000-04-14 | 2001-04-13 | Treating graft rejection with ccr5 inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001253495A1 true AU2001253495A1 (en) | 2001-10-30 |
Family
ID=24193784
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001253495A Abandoned AU2001253495A1 (en) | 2000-04-14 | 2001-04-13 | Treating graft rejection with ccr5 inhibitors |
Country Status (3)
Country | Link |
---|---|
US (1) | US20020019345A1 (en) |
AU (1) | AU2001253495A1 (en) |
WO (1) | WO2001078707A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6358979B1 (en) | 1999-06-11 | 2002-03-19 | Merck & Co., Inc. | N-cyclopentyl modulators of chemokine receptor activity |
US20020160947A1 (en) * | 2001-04-03 | 2002-10-31 | Millennium Pharmaceuticals, Inc. | Synergistic method for prolonging allograft survival |
CA2472682A1 (en) * | 2002-01-22 | 2003-07-31 | Merck & Co., Inc. | Treating stress response with chemokine receptor ccr5 modulators |
US20050245537A1 (en) * | 2002-04-24 | 2005-11-03 | Noboru Tsuchimori | Use of compounds having ccr antagonism |
AU2003266152A1 (en) * | 2002-09-13 | 2004-04-30 | University Of Maryland Biotechnology | COMPOSITIONS FOR INDUCING INCREASED LEVELS OF Beta-CHEMOKINES AND METHODS OF USE THEREFOR |
US7091211B2 (en) | 2003-07-31 | 2006-08-15 | Merck & Co., Inc. | Cyclopentyl modulators of chemokine receptor activity |
CN101918451A (en) * | 2008-01-15 | 2010-12-15 | 弗·哈夫曼-拉罗切有限公司 | Afucosylated antibody of anti-CCR5 and uses thereof |
EP3107564A4 (en) * | 2014-02-18 | 2017-08-30 | CytoDyn Inc. | Use of anti-ccr5 antibodies in graft versus host disease |
US11584797B2 (en) | 2015-06-23 | 2023-02-21 | Cytodyn Inc. | Inhibition of CCL5 ligand binding to CCR5 receptor and alteration of CCR5/CCL5 axis signaling in inflammation, cancer, autoimmune, and other conditions |
CA3045296A1 (en) | 2016-12-07 | 2018-06-14 | Progenity, Inc. | Gastrointestinal tract detection methods, devices and systems |
US10980739B2 (en) | 2016-12-14 | 2021-04-20 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor |
WO2020106757A1 (en) | 2018-11-19 | 2020-05-28 | Progenity, Inc. | Ingestible device for delivery of therapeutic agent to the gastrointestinal tract |
WO2021119482A1 (en) | 2019-12-13 | 2021-06-17 | Progenity, Inc. | Ingestible device for delivery of therapeutic agent to the gastrointestinal tract |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6024957A (en) * | 1993-06-02 | 2000-02-15 | Research Corporation Technologies, Inc. | Immunomodulators and methods for the prevention and reversal of organ transplant rejection using same |
US5919776A (en) * | 1996-12-20 | 1999-07-06 | Merck & Co., Inc. | Substituted aminoquinolines as modulators of chemokine receptor activity |
US6013644A (en) * | 1997-12-12 | 2000-01-11 | Merck & Co., Inc. | Spiro-substituted azacycles as modulators of chemokine receptor activity |
-
2001
- 2001-04-13 WO PCT/US2001/012206 patent/WO2001078707A1/en active Application Filing
- 2001-04-13 US US09/834,996 patent/US20020019345A1/en not_active Abandoned
- 2001-04-13 AU AU2001253495A patent/AU2001253495A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20020019345A1 (en) | 2002-02-14 |
WO2001078707A1 (en) | 2001-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002228435A1 (en) | Graft rejection inhibitors | |
AU2001253496A1 (en) | Treating graft rejection with cxcr3 inhibitors | |
AU2002230661A1 (en) | Implantable vascular graft | |
AU2001245437A1 (en) | Lightweight methods and compositions for well treating | |
AU2001264898A1 (en) | Ureteral stent | |
AUPQ610700A0 (en) | Automatic table game | |
AU2001288720A1 (en) | Implantable article | |
AU4882101A (en) | Mmp-12 inhibitors | |
AU2001231104A1 (en) | Methods for treating diabetes | |
AU2001243535A1 (en) | Paraffin bath | |
ZA200106160B (en) | Compositions and methods for treating cataracts. | |
AU2001253495A1 (en) | Treating graft rejection with ccr5 inhibitors | |
AU2001235988A1 (en) | Solenoid | |
AU2001279850A1 (en) | Method and arrangement for studsystem | |
AU5841600A (en) | Jewelry piece set | |
AU2001259198A1 (en) | Stent graft assembly and method | |
AUPR150700A0 (en) | Automated music arranger | |
AU2001296709A1 (en) | Gemstone | |
AU2002367184A1 (en) | Solenoid | |
AU2001236718A1 (en) | Bioreactor and related method | |
AU2001271400A1 (en) | Bioelastomer nanomachines and biosensors | |
AU2002222628A1 (en) | Keratinocyte proliferation inhibitors | |
EP1298216A4 (en) | Process for treating with enzyme | |
AU2002216930A1 (en) | System for treating vascular adhesions | |
AU2001243297A1 (en) | Method for treating or preventing depression |